The Health Guide

Critical illness

Critical illness cover and cancer: how claims work

The short answer

Cancer is the most common cause of critical illness claims, and every policy defines what counts — usually invasive malignant cancer, with some early-stage or less advanced diagnoses excluded or paid as smaller partial payments. Whether a claim succeeds turns on the written definition, so the wording matters more than the diagnosis name.

Written by Ilana Eldad. Reviewed by Muhammad Junaid.

Published . Last reviewed . Next review due .

What to know about how cancer claims work on critical illness cover

  1. Cancer causes the largest share of critical illness claims. Read more
  2. Insurers typically define cancer eligibility as an invasive malignant tumour meeting a specific severity or stage. Read more
  3. Less advanced or non-invasive diagnoses often sit on the partial-payment list instead of the main benefit. Read more
  4. Most insurers follow the ABI’s minimum-standard wording, so headline cancer definitions are broadly standardised. Read more

Thinking about how cancer claims work on critical illness cover

What works well

  • Cancer definitions follow published minimum standards.
  • Partial payments cover many less advanced diagnoses.
  • The claim tests medical evidence against the wording, not the diagnosis name.

What to watch

  • A diagnosis can be genuine yet fall short of the definition.
  • Excluded early-stage findings vary between insurers.
  • Pre-existing cancer is excluded from new cover.

The definition does the deciding

Cancer dominates critical illness claims: ABI and GRiD data confirms it as the most common single cause, and Cancer Research UK estimates one in two people born in the UK in 1961 will be diagnosed with cancer during their lifetime — which is why the cancer definition is the most important clause in the policy. Insurers define cancer claim eligibility precisely, typically requiring an invasive malignant tumour; less advanced diagnoses — certain early-stage or non-invasive findings — are commonly excluded from the main benefit and instead appear on the partial-payment list with a capped percentage of the sum assured. The practical consequence: two people with the same diagnosis name can receive different outcomes under different wordings, and the staging or grading language in the definition is what the insurer’s claims team tests the medical evidence against. The ABI publishes minimum-standard model wordings for the cancer definition that most insurers meet or exceed — the Financial Ombudsman Service’s guidance confirms the guide sets the list of illnesses and that definitions are generally standardised across the industry. This guide is about cover only — for clinical information about any cancer, see the NHS or Cancer Research UK.

If you are comparing policies, ask each insurer for its full cancer definition and its partial-payment list for less advanced diagnoses, and read them side by side before deciding. Whatever the specifics of how cancer claims work on critical illness cover, the discipline that protects you is always the same: get the insurer’s position in writing, keep the documents with the policy, and make sure the people who would help you claim know the policy exists and where the paperwork lives.

Related guides

Common questions

Why does the cancer definition matter more than the diagnosis itself?
A diagnosis of cancer does not automatically trigger the main critical illness benefit; what matters is whether the tumour, its invasiveness and its stage meet the wording the insurer has written into the policy. Two people given what sounds like the same diagnosis can see different outcomes if one meets the definition and the other falls just short of it. Because cancer is the single most common cause of critical illness claims, this one clause carries more weight than almost anything else in the document.[1]
What tends to happen to less advanced or early-stage cancer diagnoses under these policies?
Many policies treat early-stage or non-invasive findings differently from an invasive malignant tumour: rather than being excluded outright, they commonly sit on a separate partial-payment list, paying a capped percentage of the sum assured without ending the main cover. This reflects the fact that a genuine diagnosis can still fall short of the main definition, which requires a specific level of invasiveness or stage. The boundary between a main claim and the partial-payment tier is set out in the wording and differs between insurers.
How standardised are cancer definitions across different insurers?
The core cancer definition is broadly standardised, because most insurers meet or exceed the ABI’s published minimum-standard wording, and the Financial Ombudsman Service treats that guide as setting the illness list insurers should follow.[2] That consistency is strongest in the headline definition of invasive malignant cancer; it is weaker in the surrounding detail, such as which early-stage findings are excluded or paid as partial payments, where insurers differ. Ask for each insurer’s full definition rather than assume the wordings are the same.

Sources

  1. Association of British Insurers and GRiD, reported by Cover Magazine. £7.34bn paid out by protection insurers in 2023. Accessed 15 September 2026 (primary source)
  2. Financial Ombudsman Service. Critical illness cover — guidance for businesses. Accessed 15 September 2026 (primary source)